170 related articles for article (PubMed ID: 23683158)
1. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
Lin CH; Chen CC; Wang FC; Lane HY
Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
[TBL] [Abstract][Full Text] [Related]
2. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
3. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials.
Gomeni R; Merlo-Pich E
Br J Clin Pharmacol; 2007 May; 63(5):595-613. PubMed ID: 17488364
[TBL] [Abstract][Full Text] [Related]
4. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
[TBL] [Abstract][Full Text] [Related]
5. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
Lin HS; Lin CH
J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
[TBL] [Abstract][Full Text] [Related]
6. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
Lin CH; Park C; McIntyre RS
J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
8. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
[TBL] [Abstract][Full Text] [Related]
9. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD).
Ballesteros J; Bobes J; Bulbena A; Luque A; Dal-Ré R; Ibarra N; Güemes I
J Affect Disord; 2007 Sep; 102(1-3):93-9. PubMed ID: 17258323
[TBL] [Abstract][Full Text] [Related]
11. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.
Lin CH; Chen MC; Yang WC; Lane HY
Eur Neuropsychopharmacol; 2016 Feb; 26(2):225-233. PubMed ID: 26718791
[TBL] [Abstract][Full Text] [Related]
12. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.
Nelson JC; Zhang Q; Deberdt W; Marangell LB; Karamustafalioglu O; Lipkovich IA
Curr Med Res Opin; 2012 Mar; 28(3):325-34. PubMed ID: 22292447
[TBL] [Abstract][Full Text] [Related]
13. Response and remission criteria in major depression--a validation of current practice.
Riedel M; Möller HJ; Obermeier M; Schennach-Wolff R; Bauer M; Adli M; Kronmüller K; Nickel T; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Seemüller F
J Psychiatr Res; 2010 Nov; 44(15):1063-8. PubMed ID: 20447651
[TBL] [Abstract][Full Text] [Related]
14. Why do some depressed outpatients who are not in remission according to the hamilton depression rating scale nonetheless consider themselves to be in remission?
Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA
Depress Anxiety; 2012 Oct; 29(10):891-5. PubMed ID: 22887476
[TBL] [Abstract][Full Text] [Related]
15. Measuring depressive symptoms in the naturalistic primary-care setting.
McIntyre RS; Konarski JZ; Kennedy SH; Dickens SE; Bagby RM
Int J Clin Pract; 2007 Aug; 61(8):1278-82. PubMed ID: 17590219
[TBL] [Abstract][Full Text] [Related]
16. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
[TBL] [Abstract][Full Text] [Related]
17. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
Cao Y; Li W; Shen J; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of fluoxetine response for Han Chinese inpatients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
J Clin Psychopharmacol; 2011 Apr; 31(2):187-93. PubMed ID: 21346612
[TBL] [Abstract][Full Text] [Related]
19. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
20. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
